 Arleta Rewers
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Ketoacidosis | 36 | 2023 | 168 | 8.410 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2023 | 3360 | 1.760 |
Why?
| | Fluid Therapy | 11 | 2023 | 131 | 1.620 |
Why?
| | Hypoglycemia | 7 | 2020 | 400 | 0.890 |
Why?
| | Diabetes Mellitus | 7 | 2023 | 942 | 0.850 |
Why?
| | Acidosis | 1 | 2021 | 86 | 0.740 |
Why?
| | Child | 41 | 2023 | 19129 | 0.680 |
Why?
| | Insulin | 8 | 2018 | 2162 | 0.650 |
Why?
| | Adolescent | 31 | 2023 | 18480 | 0.560 |
Why?
| | Hyperglycemic Hyperosmolar Nonketotic Coma | 3 | 2022 | 5 | 0.500 |
Why?
| | Blood Glucose | 6 | 2023 | 1939 | 0.500 |
Why?
| | Child, Preschool | 19 | 2023 | 9491 | 0.440 |
Why?
| | Hypoglycemic Agents | 5 | 2022 | 1032 | 0.410 |
Why?
| | Hospitalization | 3 | 2016 | 1785 | 0.400 |
Why?
| | Colorado | 7 | 2021 | 4196 | 0.380 |
Why?
| | Sodium | 2 | 2021 | 200 | 0.370 |
Why?
| | Infant | 15 | 2023 | 8293 | 0.360 |
Why?
| | Quality Improvement | 1 | 2016 | 963 | 0.330 |
Why?
| | Diabetic Nephropathies | 2 | 2022 | 289 | 0.320 |
Why?
| | Humans | 44 | 2023 | 118974 | 0.300 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2006 | 15 | 0.300 |
Why?
| | Bicarbonates | 2 | 2017 | 44 | 0.290 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2017 | 536 | 0.270 |
Why?
| | Brain Injuries | 2 | 2022 | 484 | 0.260 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1129 | 0.260 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 151 | 0.260 |
Why?
| | Glasgow Coma Scale | 3 | 2021 | 150 | 0.260 |
Why?
| | Femoral Fractures | 1 | 2005 | 67 | 0.250 |
Why?
| | Severity of Illness Index | 8 | 2021 | 2674 | 0.250 |
Why?
| | Multiple Trauma | 1 | 2005 | 97 | 0.250 |
Why?
| | Male | 25 | 2022 | 57801 | 0.250 |
Why?
| | Acute Kidney Injury | 2 | 2021 | 709 | 0.240 |
Why?
| | Female | 25 | 2022 | 61565 | 0.240 |
Why?
| | Electrolytes | 2 | 2021 | 59 | 0.220 |
Why?
| | Hypertension | 2 | 2023 | 1203 | 0.220 |
Why?
| | Prevalence | 4 | 2022 | 2326 | 0.210 |
Why?
| | White Matter | 1 | 2023 | 115 | 0.200 |
Why?
| | Risk Factors | 9 | 2022 | 9000 | 0.200 |
Why?
| | Neurocognitive Disorders | 1 | 2020 | 25 | 0.190 |
Why?
| | Kidney Tubules | 1 | 2021 | 128 | 0.190 |
Why?
| | Communicable Disease Control | 1 | 2021 | 72 | 0.190 |
Why?
| | Brain Edema | 3 | 2018 | 61 | 0.190 |
Why?
| | Emergencies | 1 | 2020 | 153 | 0.170 |
Why?
| | Incidence | 4 | 2015 | 2424 | 0.170 |
Why?
| | Rehydration Solutions | 1 | 2018 | 8 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 301 | 0.160 |
Why?
| | Endocrinology | 1 | 2018 | 68 | 0.160 |
Why?
| | Logistic Models | 3 | 2015 | 1901 | 0.150 |
Why?
| | Emergency Service, Hospital | 4 | 2020 | 1865 | 0.150 |
Why?
| | Pediatrics | 3 | 2018 | 985 | 0.150 |
Why?
| | Cognition | 2 | 2023 | 1024 | 0.150 |
Why?
| | Pediatric Obesity | 1 | 2023 | 524 | 0.150 |
Why?
| | Length of Stay | 2 | 2016 | 1032 | 0.140 |
Why?
| | Pandemics | 2 | 2022 | 1355 | 0.140 |
Why?
| | Treatment Outcome | 3 | 2016 | 9342 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 119 | 0.140 |
Why?
| | Matrix Metalloproteinases | 1 | 2016 | 90 | 0.130 |
Why?
| | Hyperglycemia | 2 | 2020 | 312 | 0.120 |
Why?
| | Prospective Studies | 5 | 2021 | 6471 | 0.120 |
Why?
| | Insulin Infusion Systems | 1 | 2017 | 304 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2019 | 5255 | 0.110 |
Why?
| | United States | 5 | 2020 | 12555 | 0.110 |
Why?
| | Blood Pressure | 1 | 2020 | 1664 | 0.110 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 505 | 0.110 |
Why?
| | Adolescent Development | 1 | 2013 | 84 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2018 | 4596 | 0.100 |
Why?
| | Prognosis | 3 | 2020 | 3443 | 0.100 |
Why?
| | Combined Modality Therapy | 2 | 2014 | 1166 | 0.100 |
Why?
| | Patient Transfer | 1 | 2012 | 143 | 0.090 |
Why?
| | Precision Medicine | 1 | 2014 | 363 | 0.090 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2513 | 0.090 |
Why?
| | Infusions, Intravenous | 2 | 2023 | 380 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2174 | 0.090 |
Why?
| | Blood Urea Nitrogen | 3 | 2022 | 59 | 0.090 |
Why?
| | Triage | 1 | 2012 | 203 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 693 | 0.090 |
Why?
| | Cohort Studies | 4 | 2023 | 5116 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 3588 | 0.090 |
Why?
| | Emergency Medical Services | 2 | 2018 | 589 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 95 | 0.090 |
Why?
| | Sodium Chloride | 2 | 2021 | 144 | 0.090 |
Why?
| | Amylases | 1 | 2008 | 14 | 0.080 |
Why?
| | Glomerular Filtration Rate | 2 | 2023 | 683 | 0.080 |
Why?
| | Child Development | 1 | 2013 | 410 | 0.080 |
Why?
| | Consensus | 2 | 2022 | 534 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1440 | 0.080 |
Why?
| | Lipase | 1 | 2008 | 70 | 0.080 |
Why?
| | Monitoring, Physiologic | 1 | 2010 | 272 | 0.080 |
Why?
| | Dehydration | 2 | 2023 | 61 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2023 | 12978 | 0.070 |
Why?
| | Electrochemistry | 1 | 2006 | 69 | 0.070 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 736 | 0.070 |
Why?
| | Insurance, Health | 1 | 2008 | 244 | 0.070 |
Why?
| | Educational Status | 1 | 2008 | 437 | 0.070 |
Why?
| | Small-Area Analysis | 1 | 2005 | 9 | 0.070 |
Why?
| | Abbreviated Injury Scale | 1 | 2005 | 21 | 0.070 |
Why?
| | Survival Rate | 1 | 2010 | 1720 | 0.070 |
Why?
| | Models, Biological | 1 | 2012 | 1715 | 0.060 |
Why?
| | Wounds and Injuries | 1 | 2012 | 772 | 0.060 |
Why?
| | Medically Uninsured | 1 | 2005 | 125 | 0.060 |
Why?
| | International Classification of Diseases | 1 | 2005 | 122 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1384 | 0.060 |
Why?
| | Creatine | 1 | 2023 | 56 | 0.060 |
Why?
| | Aspartic Acid | 1 | 2023 | 86 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2008 | 1474 | 0.060 |
Why?
| | Choline | 1 | 2023 | 109 | 0.050 |
Why?
| | Threonine | 1 | 2022 | 45 | 0.050 |
Why?
| | Histidine | 1 | 2022 | 63 | 0.050 |
Why?
| | Electrocardiography | 1 | 2005 | 556 | 0.050 |
Why?
| | Emergency Medicine | 1 | 2005 | 238 | 0.050 |
Why?
| | Heart Diseases | 1 | 2005 | 341 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 117 | 0.050 |
Why?
| | Tryptophan | 1 | 2022 | 139 | 0.050 |
Why?
| | Glycopeptides | 1 | 2021 | 58 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2020 | 64 | 0.050 |
Why?
| | Chlorides | 1 | 2021 | 137 | 0.050 |
Why?
| | Mental Status and Dementia Tests | 1 | 2020 | 21 | 0.050 |
Why?
| | Registries | 2 | 2022 | 1810 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3057 | 0.050 |
Why?
| | Creatinine | 1 | 2022 | 491 | 0.050 |
Why?
| | Parents | 1 | 2008 | 1212 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3174 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 502 | 0.040 |
Why?
| | Acute Disease | 1 | 2002 | 940 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2023 | 969 | 0.040 |
Why?
| | Memory | 1 | 2020 | 230 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1419 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 465 | 0.040 |
Why?
| | Uric Acid | 1 | 2021 | 354 | 0.040 |
Why?
| | Clinical Competence | 1 | 2005 | 951 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 177 | 0.040 |
Why?
| | Patient Care Planning | 1 | 2018 | 143 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 953 | 0.040 |
Why?
| | Sex Factors | 1 | 2002 | 1781 | 0.040 |
Why?
| | Self Efficacy | 1 | 2018 | 366 | 0.030 |
Why?
| | Age Factors | 1 | 2002 | 2995 | 0.030 |
Why?
| | International Agencies | 1 | 2014 | 29 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 703 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2018 | 534 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2014 | 49 | 0.030 |
Why?
| | Adolescent Medicine | 1 | 2014 | 35 | 0.030 |
Why?
| | Mental Disorders | 1 | 2002 | 939 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2014 | 187 | 0.030 |
Why?
| | Adult | 3 | 2013 | 31512 | 0.030 |
Why?
| | Child Mortality | 1 | 2012 | 14 | 0.030 |
Why?
| | Syndrome | 1 | 2012 | 344 | 0.030 |
Why?
| | Exercise | 2 | 2014 | 1657 | 0.030 |
Why?
| | Brain | 1 | 2023 | 2490 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2014 | 401 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2012 | 528 | 0.020 |
Why?
| | Risk | 1 | 2013 | 853 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1200 | 0.020 |
Why?
| | Trauma Centers | 1 | 2012 | 388 | 0.020 |
Why?
| | Speech Disorders | 1 | 2009 | 35 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 97 | 0.020 |
Why?
| | Hyperventilation | 1 | 2008 | 8 | 0.020 |
Why?
| | Mood Disorders | 1 | 2009 | 119 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3171 | 0.020 |
Why?
| | Vision Disorders | 1 | 2009 | 135 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2008 | 185 | 0.020 |
Why?
| | Young Adult | 2 | 2014 | 10793 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6412 | 0.020 |
Why?
| | Hospitals, University | 1 | 2008 | 172 | 0.020 |
Why?
| | Magnesium | 1 | 2008 | 150 | 0.020 |
Why?
| | Respiration | 1 | 2008 | 183 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 167 | 0.020 |
Why?
| | Awareness | 1 | 2008 | 93 | 0.020 |
Why?
| | Eating | 1 | 2009 | 369 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 467 | 0.020 |
Why?
| | Cerebral Ventricles | 1 | 2006 | 48 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 519 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2008 | 232 | 0.020 |
Why?
| | Headache | 1 | 2006 | 128 | 0.020 |
Why?
| | Cardiology | 1 | 2005 | 272 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 411 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1795 | 0.010 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|